Averion

Aptiv Solutions acquires SRA Global Clinical Development

Thursday, October 6, 2011 01:08 PM

Reston, Va.-based Aptiv Solutions, which designs and executes adaptive clinical trials and medical device studies, has acquired SRA Global Clinical Development (GCD), the CRO division of SRA International, based in Durham, N.C., with offices in Paris, France and Milton Park, England.

More... »

Four clinical research firms become one global services organization to target niche areas

Monday, September 20, 2010 07:18 AM

Four small and mid-sized clinical research service companies—Averion International, Trio Clinical Research, Fulcrum Pharma and Clin-Research/ADDPLAN—have merged into one global biopharmaceutical and medical device development services organization that will focus on niche areas, including adaptive trials and new technologies, which can help sponsors make decisions about their drug candidates faster.

More... »

Averion Plans to Go Private

Tuesday, September 8, 2009 04:37 PM

Averion, a contract research organization (CRO) specializing in oncology, cardiovascular diseases and medical devices, has filed a statement with the Securities and Exchange Commission (SEC) as it plans to go from a publicly traded company to one that is private.

More... »

Averion Restructures as Revenues Dip

Friday, August 21, 2009 06:32 AM

Southborough, Mass.-based contract research organization (CRO) Averion is restructuring its senior management team in an effort to grow its services and improve its bottom line.

More... »

Averion’s 2008 Revenues Up 90%, Net Loss Increases by $33.5M

Thursday, April 2, 2009 08:00 AM

Full-year 2008 revenues for oncology CRO Averion increased 90% over 2007, thanks in large part to an increase in European activity and the October 2007 acquisition of Hesperion, a clinical research organization based in Switzerland. Net service revenues in 2008 were $66.4 million, compared with $34.9 million in 2007.

More... »

Averion Revenues Double Following Hesperion Acquisition

Tuesday, November 18, 2008 12:22 PM

Averion, a contract research organization (CRO) specializing in oncology, reported its third quarter revenues more than doubled following its acquisition of Swiss CRO Hesperion.

More... »

Etrials Appoints Permanent CEO

Friday, November 14, 2008 09:00 AM

Just a day after releasing disappointing third quarter results, Morrisville, N.C.-based eClinical company etrials named a new president and CEO, M. Denis Connaghan, replacing interim president and CEO Chuck Piccirillo. Piccirillo, who will resume his position as vice president of technology, has served as interim CEO since the resignation of Eugene “Chip” Jennings in July. Connaghan was formerly managing director within Marsh USA’s Global Operations.

More... »

Averion Expands European Operations

Wednesday, October 8, 2008 01:06 PM

Averion, a contract research organization (CRO) specializing in oncology, cardiovascular diseases and medical devices, has expanded its European operations by opening an office in the Czech Republic.

More... »

Averion Names Executive Vice President of Global Biz Dev

Wednesday, August 20, 2008 09:00 AM

Averion International, an international contract research organization (CRO) specializing in oncology and cardiovascular diseases, appointed Peter Gonze executive vice president of global business development, a role that will focus on increasing Averion’s business efforts in international markets.

More... »

Averion Ramps up in Eastern Europe with Ukraine Office

Monday, August 4, 2008 05:21 AM

Adding yet another key Eastern European country to its footprint in the region, Southborough,Mass.-based contract research organization (CRO) Averion has opened an office in Kiev, Ukraine—the country’s capital and largest city. The office is being led by Evgeny Levenko, M.D., PhD, Averion’s affiliate manager for Ukraine.

More... »